Spring Bank Pharmaceuticals Presents Data on STING Agonist SB 11285 at the AACR Special Conference on Tumor Immunology and Immunotherapy
October 20, 2016 07:30 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals to Present at Dawson James Securities 2016 Stock Growth Conference
October 13, 2016 07:30 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals Abstracts on STING Agonist SB 11285 Accepted for Poster Presentations at AACR Special Conference on Tumor Immunology and Immunotherapy
September 06, 2016 16:05 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals, Inc. to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City on September 13th, 2016
August 22, 2016 17:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals Announces Second Quarter 2016 Financial Results and Recent Highlights
August 01, 2016 17:14 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals Appoints Dr. Todd C. Brady to its Board of Directors
July 28, 2016 16:05 ET
|
Spring Bank Pharmaceuticals Inc.
MILFORD, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals Added to Russell Microcap® Index
June 27, 2016 08:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., June 27, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals Doses the First Patient in the ACHIEVE Global Phase 2 Program of SB 9200 in Hepatitis B (HBV)
June 22, 2016 08:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., June 22, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals to Present at Upcoming Investor Conferences
May 25, 2016 08:00 ET
|
Spring Bank Pharmaceuticals, Inc.
MILFORD, Mass., May 25, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals Announces Closing of Initial Public Offering
May 11, 2016 14:17 ET
|
Spring Bank Pharmaceuticals, Inc.
MILFORD, Mass., May 11, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral...